These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25395376)

  • 1. Patenting stem cell technologies in Europe.
    Sheard A
    Cold Spring Harb Perspect Med; 2014 Nov; 5(3):a021089. PubMed ID: 25395376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for stem cell patent applications in the light of recent court cases.
    Eyre DE; Schlich GW
    Pharm Pat Anal; 2015; 4(6):431-41. PubMed ID: 26580992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patent eligibility of stem cells in Europe: where do we stand after 8 years of case law?
    Storz U; Faltus T
    Regen Med; 2017 Jan; 12(1):37-51. PubMed ID: 27976982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brüstle v. Greenpeace: Implications for Commercialisation of Translational Stem Cell Research.
    Mansnérus J
    Eur J Health Law; 2015 Apr; 22(2):141-64. PubMed ID: 26399054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Patentability of Stem Cells in Australia.
    Petering J; Cowin P
    Cold Spring Harb Perspect Med; 2015 Jul; 5(10):. PubMed ID: 26134481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical questions to ponder in the European stem cell patent debate.
    Curley D; Sharples A
    J Biolaw Bus; 2006; 9(3):12-6. PubMed ID: 17152135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Legal and regulatory news from Europe.
    Hitchcock J
    Stem Cells Dev; 2014 Dec; 23 Suppl 1():44-6. PubMed ID: 25457961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Europe. Dismay, confusion greet human stem cell patent ban.
    Vogel G
    Science; 2011 Oct; 334(6055):441-2. PubMed ID: 22034406
    [No Abstract]   [Full Text] [Related]  

  • 9. European stem cell research in legal shackles.
    Nielen MG; de Vries SA; Geijsen N
    EMBO J; 2013 Dec; 32(24):3107-11. PubMed ID: 24270573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revocation of European patent for neural progenitors highlights patent challenges for inventions relating to human embryonic stem cells.
    Rigby B
    Expert Opin Ther Pat; 2013 Nov; 23(11):1395-8. PubMed ID: 24079708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patents on inventions related to human embryonic stem cells: the morality clause after Brüstle v. Greenpeace.
    Panis S
    Med Law; 2013 Sep; 32(3):347-72. PubMed ID: 24340486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patenting, morality and human embryonic stem cell science: bioethics and cultural politics in Europe.
    Salter B
    Regen Med; 2007 May; 2(3):301-11. PubMed ID: 17511566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patentability of Parthenogenic Stem Cells: International Stem Cell Corporation v. Comptroller General of Patents.
    Mansnérus J
    Eur J Health Law; 2015 Jun; 22(3):267-86. PubMed ID: 26399046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The European Court of Justice ruling in Brüstle v. Greenpeace: the impacts on patenting of human induced pluripotent stem cells in Europe.
    Triller Vrtovec K; Scott CT
    Cell Stem Cell; 2011 Dec; 9(6):502-3. PubMed ID: 22136925
    [No Abstract]   [Full Text] [Related]  

  • 15. Europe rules against stem-cell patents.
    Abbott A
    Nature; 2011 Mar; 471(7338):280. PubMed ID: 21412307
    [No Abstract]   [Full Text] [Related]  

  • 16. The European Court of Justice's decision regarding the Brüstle patent and its implications for the legality of stem cell research within the European Union.
    Heyer M; Spranger TM
    Stem Cells Dev; 2013 Dec; 22 Suppl 1():50-3. PubMed ID: 24304076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No patent-no therapy: a matter of moral and legal consistency within the European Union regarding the use of human embryonic stem cells.
    Faltus T
    Stem Cells Dev; 2014 Dec; 23 Suppl 1():56-9. PubMed ID: 25457964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioethical ambition, political opportunity and the European governance of patenting: the case of human embryonic stem cell science.
    Salter B; Salter C
    Soc Sci Med; 2013 Dec; 98():286-92. PubMed ID: 23312796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ethics of patenting human embryonic stem cells.
    Chapman AR
    Kennedy Inst Ethics J; 2009 Sep; 19(3):261-88. PubMed ID: 19886524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patenting human pluripotent cells: balancing commercial, academic and ethical interests.
    Bahadur G; Morrison M
    Hum Reprod; 2010 Jan; 25(1):14-21. PubMed ID: 19897856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.